BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...
A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a 70-year old woman with a prior history of ...
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot ...
TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Receive the the latest news, research, and ...
The burden of subclinical atrial fibrillation didn’t predict stroke or other embolic events or the impact of direct oral ...
Dear Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I've been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results